Status:
UNKNOWN
Effects of Prophylactic Desmopressin on Blood Coagulation Parameters in Heart Valve Surgery
Lead Sponsor:
Instituto do Coracao
Conditions:
C.Surgical Procedure; Cardiac
Blood Coagulation Disorders
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The purpose of this study is evaluate the effect of prophylactic desmopressin on blood coagulation parameters and postoperative bleeding in patients undergoing valve cardiac surgery with cardiopulmona...
Detailed Description
Patients with important valve disorders may evaluate with coagulopathy induced by mechanical effects (valvular stenosis or valvular insufficiency). Furthermore, frequently is required prophylactic use...
Eligibility Criteria
Inclusion
- Valve cardiac surgery with cardiopulmonary bypass.
- Written informed consent
Exclusion
- Reoperative valve surgery
- Hematocrit \< 35%
- Ventricular dysfunction (EF \< 40%)
- Infection
- Body mass index \> 35
- Renal impairment (Creatinin \> 2mg/dL)
- Antiplatelet administration within 10 days preceding study surgery
- Participation in another interventional clinical study within 30 days
- Known or suspected hypersensitivity to the desmopressin
- Coagulopathy (INR \> 1.5)
Key Trial Info
Start Date :
February 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2017
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT03343418
Start Date
February 1 2015
End Date
November 1 2017
Last Update
November 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Incor - Heart Institute - University of Sao Paulo
São Paulo, Brazil, 05403000